1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Bovonex Inc. currently has 1 pending office action. This action is assigned to WILLIAMS, CATHERINE SERKE, who is the 1 examiner currently active on the company's pending files. The prosecution is localized in 1 distinct art unit, indicating a focused technical review despite the absence of a broad technology area classification. For a practitioner, the presence of 1 pending office action under 1 examiner means the immediate strategy is singular. There is no need to coordinate across different art units or examiner styles.
WILLIAMS, CATHERINE SERKE, as the busiest examiner with 1 pending action, handles the entirety of the company's current USPTO workload. This profile indicates a highly concentrated prosecution effort where the practitioner can focus on a 1 set of examiner preferences. The administrative overhead is minimal given the low volume of pending matters. Success in this 1 action is critical as it represents the whole of the company's current pending activity at the USPTO. Practitioners should prioritize direct communication with WILLIAMS, CATHERINE SERKE to advance this matter within the 1 distinct art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WILLIAMS, CATHERINE SERKE | 1 | 62.5% | +29.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18840935 | METHOD AND APPARATUS FOR MEDICAL INJECTION | WILLIAMS, CATHERINE SERKE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18840935 | METHOD AND APPARATUS FOR MEDICAL INJECTION | WILLIAMS, CATHERINE SERKE | — |
| Art Unit | Apps |
|---|---|
| 3993 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18840935 | METHOD AND APPARATUS FOR MEDICAL INJECTION | WILLIAMS, CATHERINE SERKE | 3993 | §102§103 | Non-Final OA | — | Pending | Aug 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBovonex Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Catherine Serke Williams has the most, with 1 of Bovonex Inc.'s pending office actions.